翻译后丢失。 - Suppr

Suppr

超能文献

[Lost after translation].

作者信息

Kaplan Jean-Claude

出版信息

Med Sci (Paris). 2008 Nov;24(11):912-5. doi: 10.1051/medsci/20082411912.

DOI:10.1051/medsci/20082411912

PMID:19038089

Abstract

摘要

相似文献

[Lost after translation].

Med Sci (Paris). 2008 Nov;24(11):912-5. doi: 10.1051/medsci/20082411912.

Patient page. Gene therapy and muscular dystrophies.

Neurology. 2008 Jul 22;71(4):e6-8. doi: 10.1212/01.wnl.0000324282.19778.b5.

Sarcoglycans in muscular dystrophy.

Microsc Res Tech. 2000;48(3-4):167-80. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T.

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

Muscle Nerve. 1994 Jan;17(1):2-15. doi: 10.1002/mus.880170103.

Genetic background influences muscular dystrophy.

Neuromuscul Disord. 2005 Oct;15(9-10):601-9. doi: 10.1016/j.nmd.2005.05.004.

[Molecular basis of inherited muscular diseases].

No To Shinkei. 1995 Aug;47(8):735-48.

Therapy insight: cardiovascular complications associated with muscular dystrophies.

Nat Clin Pract Cardiovasc Med. 2005 Jun;2(6):301-8. doi: 10.1038/ncpcardio0213.

Muscular dystrophy meets the mesangioblast.

Nat Med. 2003 Aug;9(8):999. doi: 10.1038/nm0803-999a.

Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

Nat Genet. 1999 Nov;23(3):338-42. doi: 10.1038/15519.

Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.

Exp Cell Res. 2006 May 15;312(9):1610-25. doi: 10.1016/j.yexcr.2006.01.024. Epub 2006 Mar 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Lost after translation].

Med Sci (Paris). 2008 Nov;24(11):912-5. doi: 10.1051/medsci/20082411912.

Patient page. Gene therapy and muscular dystrophies.

Neurology. 2008 Jul 22;71(4):e6-8. doi: 10.1212/01.wnl.0000324282.19778.b5.

Sarcoglycans in muscular dystrophy.

Microsc Res Tech. 2000;48(3-4):167-80. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T.

Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.

Muscle Nerve. 1994 Jan;17(1):2-15. doi: 10.1002/mus.880170103.

Genetic background influences muscular dystrophy.

Neuromuscul Disord. 2005 Oct;15(9-10):601-9. doi: 10.1016/j.nmd.2005.05.004.

[Molecular basis of inherited muscular diseases].

No To Shinkei. 1995 Aug;47(8):735-48.

Therapy insight: cardiovascular complications associated with muscular dystrophies.

Nat Clin Pract Cardiovasc Med. 2005 Jun;2(6):301-8. doi: 10.1038/ncpcardio0213.

Muscular dystrophy meets the mesangioblast.

Nat Med. 2003 Aug;9(8):999. doi: 10.1038/nm0803-999a.

Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

Nat Genet. 1999 Nov;23(3):338-42. doi: 10.1038/15519.

Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.

Exp Cell Res. 2006 May 15;312(9):1610-25. doi: 10.1016/j.yexcr.2006.01.024. Epub 2006 Mar 9.